Shailja V Parikh

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered(More)
  • 1